Biotech can be a gamble. I like a company like tetraphase. Taking something already known to be an effective weapon against infection and altering it just enough to gain intellectual rights as well as clear medical benefit in a world.troubled by constantly mutating infectious.disease...is a sure shot.
I have 2100 shares and will use them as a hedge thru thick and thin. I will use my profits from mnkd to double down if it drops from here. Target sell $14 upon release of phase III data.